{
    "document_id": "D-2024-3001",
    "LinkTitle": "D-2024-3001",
    "file_name": "D-2024-3001.pdf",
    "file_path": "/Users/JADEPOTTER5/Downloads/DMP-MT/processed_data/pdfs_new/org_pdfs/D-2024-3001.pdf",
    "metadata": {
        "title": "A high-throughput experimental evolution platform for the flexible optimization of antimicrobial probiotic and biocontrol strains",
        "author": "N/A",
        "creation_date": "2024-11-29 09:21:42+00:00",
        "num_pages": 6
    },
    "content": {
        "full_text": "A high-throughput experimental evolution platform for the flexible optimization of antimicrobial\nA high-throughput experimental evolution platform for the flexible optimization of antimicrobial\nprobiotic and biocontrol strains\nprobiotic and biocontrol strains\nFWO DMP (Flemish Standard DMP)\nFWO DMP (Flemish Standard DMP)\n1. Research Data Summary\n1. Research Data Summary\nList and describe all datasets or research materials that you plan to generate/collect or reuse during your research project. For\nList and describe all datasets or research materials that you plan to generate/collect or reuse during your research project. For\neach dataset or data type (observational, experimental etc.), provide a short name & description (sufficient for yourself to know\neach dataset or data type (observational, experimental etc.), provide a short name & description (sufficient for yourself to know\nwhat data it is about), indicate whether the data are newly generated/collected or reused, digital or physical, also indicate the type\nwhat data it is about), indicate whether the data are newly generated/collected or reused, digital or physical, also indicate the type\nof the data (the kind of content), its technical format (file extension), and an estimate of the upper limit of the volume of the data.\nof the data (the kind of content), its technical format (file extension), and an estimate of the upper limit of the volume of the data.\n \n \n \n \nOnly for digital data\nOnly for\ndigital data \nOnly for\ndigital data \nOnly for\nphysical\ndata\nDataset Name\nDescription\nNew or reused\nDigital or\nPhysical\nDigital Data Type\nDigital Data\nformat\nDigital data\nvolume\n(MB/GB/TB)\nPhysical\nvolume\n \n \nPlease choose\nfrom the\nfollowing\noptions:\nGenerate\nnew data\nReuse\nexisting\ndata\nPlease\nchoose from\nthe following\noptions:\nDigital\nPhysical\nPlease choose from the\nfollowing options:\nObservational\nExperimental\nCompiled/aggregated\ndata\nSimulation data\nSoftware\nOther\nNA\nPlease\nchoose from\nthe following\noptions:\n.por,\n.xml,\n.tab,\n.csv,.pdf,\n.txt, .rtf,\n.dwg,\n.gml, …\nNA\nPlease\nchoose from\nthe following\noptions:\n<100MB\n<1GB\n<100GB\n<1TB\n<5TB\n<10TB\n<50TB\n>50TB\nNA\n \nMicrobial cell\ncounts via\nflow cytomtery\nRead-out for all\nthe bacterial\ncompetition and\nfitness assays\n(both in vitro and\nin vivo)\nGenerate new\ndata\nDigital\nExperimental\n.xls\n<1GB\n \nMicrobial cell\ncounts via CFU\nRead-out for all\nthe bacterial\ncompetition and\nfitness assays\n(both in vitro and\nin vivo)\nGenerate new\ndata\nDigital\nExperimental\n.fcs\n<100GB\n \nBacterial\nbiomass\nproduction\nMeasurements\nof biofilm\nbiomass via\ncrystal violet\nassay\nGenerate new\ndata\nDigital\nExperimental\n.xls\n<1GB\n \nOptical density\nmeasurements\nMeasurements\nof bacterial\npopulation\ndensities based\non optical\ndensity\nGenerate new\ndata\nDigital\nExperimental\n.xls\n<100MB\n \nMicroscopy\nimages\nMicroscopy\nimages of\nbacterial\nbiofilms and\nwound tissues\nGenerate new\ndata\nDigital\nExperimental\n.czi\n.tiff\n<100GB\n \nCreated using DMPonline.be. Last modiﬁed 04 October 2024\n1 of 6\nWhole genome\nsequencing\nWGS data of the\nancestral and\nselected evolved\nstrains\nGenerate new\ndata\nDigital\nExperimental\n.FASTQ\n.BAM\n \n<5TB\n \nRNA\nsequencing\nRNA-sequencing\nof the ancestral\nand selected\nevolved strains\nGenerate new\ndata\nDigital\nExperimental\n.FASTQ\n.BAM\n<1TB\n \nEvolved\nbacteria\nEvolved bacterial\npopulations and\nisolated clones\nfrom the evolved\npopulations\nGenerate new\ndata\nPhysical\n \n \n \n~5000-\n10000\nsamples,\nstored in\n96-well\nplate format\nPorcine tissue\nsamples\nWound biopsies\nfor\nhistopathological\nanalysis\nGenerate new\ndata\nPhysical\n \n \n \n~50\nsamples,\nembedded\nin paraffin,\nstored at\nroom\ntemperature\nRT-qPCR\nqPCR\nmeasurements\nof the immune\nresponse in the \nporcine trials\nand the\nconfirmation of\nof\nAgrobacterium\ninfection in the \ngreen house\ntrials\nGenerate new\ndata\nDigital\nExperimental\n.SDS\n<100MB\n \nIf you reuse existing data, please specify the source, preferably by using a persistent identifier (e.g. DOI, Handle, URL etc.) per\nIf you reuse existing data, please specify the source, preferably by using a persistent identifier (e.g. DOI, Handle, URL etc.) per\ndataset or data type:\ndataset or data type:\nWe will make use of a published reference genomes of \nL. rhamnosus\n GG (NCBI RefSeq assembly GCF_000011045.1) to map our\nwhole genome and RNA sequencing data.\nAre there any ethical issues concerning the creation and/or use of the data (e.g. experiments on humans or animals, dual use)?\nAre there any ethical issues concerning the creation and/or use of the data (e.g. experiments on humans or animals, dual use)?\nDescribe these issues in the comment section. Please refer to specific datasets or data types when appropriate.\nDescribe these issues in the comment section. Please refer to specific datasets or data types when appropriate.\nYes, animal data\nIn \nvivo\n validation of the evolved probiotic strains are planned in project year 3. An application to the animal ethical committee of\nthe KU Leuven will be submitted once the required preliminary data is collected.\nWill you process personal data? If so, briefly describe the kind of personal data you will use in the comment section. Please refer\nWill you process personal data? If so, briefly describe the kind of personal data you will use in the comment section. Please refer\nto specific datasets or data types when appropriate.\nto specific datasets or data types when appropriate.\nNo\nDoes your work have potential for commercial valorization (e.g. tech transfer, for example spin-offs, commercial exploitation, …)?\nDoes your work have potential for commercial valorization (e.g. tech transfer, for example spin-offs, commercial exploitation, …)?\nIf so, please comment per dataset or data type where appropriate.\nIf so, please comment per dataset or data type where appropriate.\nCreated using DMPonline.be. Last modiﬁed 04 October 2024\n2 of 6\nYes\nBoth the improved probiotic strains and the experimental evolution platform will be valorized. IP will be protected by coyright and\npatent applications.\nThe project Exploitation Committee will assess the opportunity of patenting, monitor developments in the targeted markets, re-\nalign the project’s R&D objectives if need be according to the evolving needs of the industrial end-users, seek out potential\napplication areas and business opportunities for the project’s developed technology, and generate and update the dissemination\nand exploitation plan of the R&D results.\nDo existing 3rd party agreements restrict exploitation or dissemination of the data you (re)use (e.g. Material/Data transfer\nDo existing 3rd party agreements restrict exploitation or dissemination of the data you (re)use (e.g. Material/Data transfer\nagreements/ research collaboration agreements)? If so, please explain in the comment section to what data they relate and what\nagreements/ research collaboration agreements)? If so, please explain in the comment section to what data they relate and what\nrestrictions are in place.\nrestrictions are in place.\nNo\nAre there any other legal issues, such as intellectual property rights and ownership, to be managed related to the data you\nAre there any other legal issues, such as intellectual property rights and ownership, to be managed related to the data you\n(re)use? If so, please explain in the comment section to what data they relate and which restrictions will be asserted.\n(re)use? If so, please explain in the comment section to what data they relate and which restrictions will be asserted.\nNo\nWe have FTO for the probiotic and biocontrol strains selected for the different case studies. The IP on the Paenibacillus strain is\nowned by KU Leuven, whereas the patents covering the use of Bacillus and Lactabcillus in the envision application are expired or\naborted.\n2. Documentation and Metadata\n2. Documentation and Metadata\nClearly describe what approach will be followed to capture the accompanying information necessary to keep data understandable\nClearly describe what approach will be followed to capture the accompanying information necessary to keep data understandable\nand usable, for yourself and others, now and in the future (e.g., in terms of documentation levels and types required, procedures\nand usable, for yourself and others, now and in the future (e.g., in terms of documentation levels and types required, procedures\nused, Electronic Lab Notebooks, README.txt files, Codebook.tsv etc. where this information is recorded).\nused, Electronic Lab Notebooks, README.txt files, Codebook.tsv etc. where this information is recorded).\n1. The data will be accompanied by a detailed metadata txt file denoting important\ncharacteristics (e.g. strain, material, time point,..) necessary for interpretation of the\nresults. The key characteristics will also be denoted in the filename of the data\nfiles.\n2. A detailed experimental protocol will be added to the directory of the\ncorresponding experimental results. This step-wise description will facilitate potential\nfuture reproduction of the experiments.\n3. For every deliverable in the project, a general outline txt file will be created. This file provides an overview of all the available\ndata, the design of the experiment and the structure of the data saving.\nWill a metadata standard be used to make it easier to find and reuse the data? If so, please specify (where appropriate per\nWill a metadata standard be used to make it easier to find and reuse the data? If so, please specify (where appropriate per\ndataset or data type) which metadata standard will be used. If not, please specify (where appropriate per dataset or data type)\ndataset or data type) which metadata standard will be used. If not, please specify (where appropriate per dataset or data type)\nwhich metadata will be created to make the data easier to find and reuse.\nwhich metadata will be created to make the data easier to find and reuse.\nYes\nMicroscopy data: OME-XML metadata standard\nSequencing data: MIxS metadata standard \nFlow cytometry data: MIFlowCyt metadata standard\nqPCR data: MIQE metadata standard \nA metadata template will be constructed in the frame of the project for data types where no general metadata standard is\navailable.\nCreated using DMPonline.be. Last modiﬁed 04 October 2024\n3 of 6\n3. Data storage & back-up during the research project\n3. Data storage & back-up during the research project\nWhere will the data be stored?\nWhere will the data be stored?\n1. Data generated by the different partners will be saved on a collective sharepoint\nfor the data during the project. In view of the size of the raw microscopy and sequencing data,these data will be exempt from the\nsharepoint.\n2. Additionally each partner will store their generated data on the central storage facility of their respective research units with the\nsame structure as the sharepoints.\n3. Personal copies can be made and kept on personal devices.\nHow will the data be backed up?\nHow will the data be backed up?\n1. The collective sharepoint is backed up three times per day.\n2. The internal back-up of the specific partners is managed according the procedures of their respective research institutions.\nIs there currently sufficient storage & backup capacity during the project? If yes, specify concisely.\nIs there currently sufficient storage & backup capacity during the project? If yes, specify concisely.\nIf no or insufficient storage or backup capacities are available, then explain how this will be taken care of.\nIf no or insufficient storage or backup capacities are available, then explain how this will be taken care of.\nYes\nSufficient storage space is provided by the respective research institutions.\nHow will you ensure that the data are securely stored and not accessed or modified by unauthorized persons?\nHow will you ensure that the data are securely stored and not accessed or modified by unauthorized persons?\n1. Viewing and modification rights in sharepoint are granted based on the involvement in the specific work packages.\n2. Critical documents, e.g. reports, presentations,... can\nbe (temporarily) locked by the author(s).\n3. Sharepoint provides a changelog for detecting and reverting possible unauthorized changes.\n4. The internal storage of the partners provides a back-up for the sharepoint and vice versa.\n5. Physical data is stored in a secured -80°C freezer at the facility with limited-access.\nWhat are the expected costs for data storage and backup during the research project? How will these costs be covered?\nWhat are the expected costs for data storage and backup during the research project? How will these costs be covered?\n1. The total cost of storage are estimated on ~€3000-€3500 per year, mainly for the raw sequencing data (~4TB).\n2.The costs will be covered by the respective partners using the allocated project budget (working budget: consumables).\n4. Data preservation after the end of the research project\n4. Data preservation after the end of the research project\nWhich data will be retained for at least five years (or longer, in agreement with other retention policies that are applicable) after\nWhich data will be retained for at least five years (or longer, in agreement with other retention policies that are applicable) after\nthe end of the project? In case some data cannot be preserved, clearly state the reasons for this (e.g. legal or contractual\nthe end of the project? In case some data cannot be preserved, clearly state the reasons for this (e.g. legal or contractual\nrestrictions, storage/budget issues, institutional policies...).\nrestrictions, storage/budget issues, institutional policies...).\nAll of the generated data will be stored for minimum 5 years after the end of the\nproject.\nCreated using DMPonline.be. Last modiﬁed 04 October 2024\n4 of 6\nWhere will these data be archived (stored and curated for the long-term)?\nWhere will these data be archived (stored and curated for the long-term)?\n1. Every partner will store their generated data for at least 5 years according to the\nstorage and back-up procedures present at their research institute. 2. The project\ncoordinator will store the total generated data in the research project using the archive\nnetwork (K:) drives provided by the KU Leuven.\nWhat are the expected costs for data preservation during the expected retention period? How will these costs be covered?\nWhat are the expected costs for data preservation during the expected retention period? How will these costs be covered?\nIn light of the size of the sequencing data (4 TB), the current storage volume of the\narchive drive at KU Leuven needs to be increased. The costs for an expansion of 4 TB\nfor 5 years are estimated on € 4,000, and will be covered by the allocated project\nbudget.\n5. Data sharing and reuse\n5. Data sharing and reuse\nWill the data (or part of the data) be made available for reuse after/during the project?  In the comment section please explain per\nWill the data (or part of the data) be made available for reuse after/during the project?  In the comment section please explain per\ndataset or data type which data will be made available.\ndataset or data type which data will be made available.\nYes, in an Open Access repository\nAll digital data will be made available upon publication. The evolved bacterial strains will not be made available in order to protect\nthe valorisation potential of these strains.\n  \nIf access is restricted, please specify who will be able to access the data and under what conditions.\nIf access is restricted, please specify who will be able to access the data and under what conditions.\nn/a\nAre there any factors that restrict or prevent the sharing of (some of) the data (e.g. as defined in an agreement with a 3rd party,\nAre there any factors that restrict or prevent the sharing of (some of) the data (e.g. as defined in an agreement with a 3rd party,\nlegal restrictions)? Please explain in the comment section per dataset or data type where appropriate.\nlegal restrictions)? Please explain in the comment section per dataset or data type where appropriate.\nNo\nWhere will the data be made available? If already known, please provide a repository per dataset or data type.\nWhere will the data be made available? If already known, please provide a repository per dataset or data type.\nThe sequencing data will be deposited International Nucleotide Sequence Database Collaboration (INSDC).\nWhen will the data be made available?\nWhen will the data be made available?\nThe data will be made available upon publication of the corresponding research results.\nWhich data usage licenses are you going to provide? If none, please explain why.\nWhich data usage licenses are you going to provide? If none, please explain why.\nWe will make use of open licenses such as CC-BY or their equivalent as our data is not considered sensitive and open licenses are\noften required for high impact publications.\nCreated using DMPonline.be. Last modiﬁed 04 October 2024\n5 of 6\nDo you intend to add a PID/DOI/accession number to your dataset(s)? If already available, you have the option to provide it in the\nDo you intend to add a PID/DOI/accession number to your dataset(s)? If already available, you have the option to provide it in the\ncomment section.\ncomment section.\nYes\nWhat are the expected costs for data sharing? How will these costs be covered?\nWhat are the expected costs for data sharing? How will these costs be covered?\nNo costs are expected.\n6. Responsibilities\n6. Responsibilities\nWho will manage data documentation and metadata during the research project?\nWho will manage data documentation and metadata during the research project?\nThe WP leaders carry the end responsibility for the correct documentation of the data generated in their respective WP \nWho will manage data storage and backup during the research project?\nWho will manage data storage and backup during the research project?\nEach partner is responsible for correct data storage, i.e. sharepoint and internal, for the duration of the project. The project\ncoordinator is responsible for the coordination of the data storage \nWho will manage data preservation and sharing?\nWho will manage data preservation and sharing?\nThe coordinator of the project will collect all the data after the project and ensure correct preservation of the data \nWho will update and implement this DMP?\nWho will update and implement this DMP?\nThe coordinator, together with the project partners, bears the end responsibility of updating & implementing this DMP. \nCreated using DMPonline.be. Last modiﬁed 04 October 2024\n6 of 6"
    },
    "clean_full_text": "A high-throughput experimental evolution platform for the flexible optimization of antimicrobial A high-throughput experimental evolution platform for the flexible optimization of antimicrobial probiotic and biocontrol strains probiotic and biocontrol strains FWO DMP (Flemish Standard DMP) FWO DMP (Flemish Standard DMP) 1. Research Data Summary 1. Research Data Summary List and describe all datasets or research materials that you plan to generate/collect or reuse during your research project. For List and describe all datasets or research materials that you plan to generate/collect or reuse during your research project. For each dataset or data type (observational, experimental etc.), provide a short name & description (sufficient for yourself to know each dataset or data type (observational, experimental etc.), provide a short name & description (sufficient for yourself to know what data it is about), indicate whether the data are newly generated/collected or reused, digital or physical, also indicate the type what data it is about), indicate whether the data are newly generated/collected or reused, digital or physical, also indicate the type of the data (the kind of content), its technical format (file extension), and an estimate of the upper limit of the volume of the data. of the data (the kind of content), its technical format (file extension), and an estimate of the upper limit of the volume of the data. Only for digital data Only for digital data Only for digital data Only for physical data Dataset Name Description New or reused Digital or Physical Digital Data Type Digital Data format Digital data volume (MB/GB/TB) Physical volume Please choose from the following options: Generate new data Reuse existing data Please choose from the following options: Digital Physical Please choose from the following options: Observational Experimental Compiled/aggregated data Simulation data Software Other NA Please choose from the following options: .por, .xml, .tab, .csv,.pdf, .txt, .rtf, .dwg, .gml, … NA Please choose from the following options: <100MB <1GB <100GB <1TB <5TB <10TB <50TB >50TB NA Microbial cell counts via flow cytomtery Read-out for all the bacterial competition and fitness assays (both in vitro and in vivo) Generate new data Digital Experimental .xls <1GB Microbial cell counts via CFU Read-out for all the bacterial competition and fitness assays (both in vitro and in vivo) Generate new data Digital Experimental .fcs <100GB Bacterial biomass production Measurements of biofilm biomass via crystal violet assay Generate new data Digital Experimental .xls <1GB Optical density measurements Measurements of bacterial population densities based on optical density Generate new data Digital Experimental .xls <100MB Microscopy images Microscopy images of bacterial biofilms and wound tissues Generate new data Digital Experimental .czi .tiff <100GB Created using DMPonline.be. Last modiﬁed 04 October 2024 1 of 6 Whole genome sequencing WGS data of the ancestral and selected evolved strains Generate new data Digital Experimental .FASTQ .BAM <5TB RNA sequencing RNA-sequencing of the ancestral and selected evolved strains Generate new data Digital Experimental .FASTQ .BAM <1TB Evolved bacteria Evolved bacterial populations and isolated clones from the evolved populations Generate new data Physical ~5000- 10000 samples, stored in 96-well plate format Porcine tissue samples Wound biopsies for histopathological analysis Generate new data Physical ~50 samples, embedded in paraffin, stored at room temperature RT-qPCR qPCR measurements of the immune response in the porcine trials and the confirmation of of Agrobacterium infection in the green house trials Generate new data Digital Experimental .SDS <100MB If you reuse existing data, please specify the source, preferably by using a persistent identifier (e.g. DOI, Handle, URL etc.) per If you reuse existing data, please specify the source, preferably by using a persistent identifier (e.g. DOI, Handle, URL etc.) per dataset or data type: dataset or data type: We will make use of a published reference genomes of L. rhamnosus GG (NCBI RefSeq assembly GCF_000011045.1) to map our whole genome and RNA sequencing data. Are there any ethical issues concerning the creation and/or use of the data (e.g. experiments on humans or animals, dual use)? Are there any ethical issues concerning the creation and/or use of the data (e.g. experiments on humans or animals, dual use)? Describe these issues in the comment section. Please refer to specific datasets or data types when appropriate. Describe these issues in the comment section. Please refer to specific datasets or data types when appropriate. Yes, animal data In vivo validation of the evolved probiotic strains are planned in project year 3. An application to the animal ethical committee of the KU Leuven will be submitted once the required preliminary data is collected. Will you process personal data? If so, briefly describe the kind of personal data you will use in the comment section. Please refer Will you process personal data? If so, briefly describe the kind of personal data you will use in the comment section. Please refer to specific datasets or data types when appropriate. to specific datasets or data types when appropriate. No Does your work have potential for commercial valorization (e.g. tech transfer, for example spin-offs, commercial exploitation, …)? Does your work have potential for commercial valorization (e.g. tech transfer, for example spin-offs, commercial exploitation, …)? If so, please comment per dataset or data type where appropriate. If so, please comment per dataset or data type where appropriate. Created using DMPonline.be. Last modiﬁed 04 October 2024 2 of 6 Yes Both the improved probiotic strains and the experimental evolution platform will be valorized. IP will be protected by coyright and patent applications. The project Exploitation Committee will assess the opportunity of patenting, monitor developments in the targeted markets, re- align the project’s R&D objectives if need be according to the evolving needs of the industrial end-users, seek out potential application areas and business opportunities for the project’s developed technology, and generate and update the dissemination and exploitation plan of the R&D results. Do existing 3rd party agreements restrict exploitation or dissemination of the data you (re)use (e.g. Material/Data transfer Do existing 3rd party agreements restrict exploitation or dissemination of the data you (re)use (e.g. Material/Data transfer agreements/ research collaboration agreements)? If so, please explain in the comment section to what data they relate and what agreements/ research collaboration agreements)? If so, please explain in the comment section to what data they relate and what restrictions are in place. restrictions are in place. No Are there any other legal issues, such as intellectual property rights and ownership, to be managed related to the data you Are there any other legal issues, such as intellectual property rights and ownership, to be managed related to the data you (re)use? If so, please explain in the comment section to what data they relate and which restrictions will be asserted. (re)use? If so, please explain in the comment section to what data they relate and which restrictions will be asserted. No We have FTO for the probiotic and biocontrol strains selected for the different case studies. The IP on the Paenibacillus strain is owned by KU Leuven, whereas the patents covering the use of Bacillus and Lactabcillus in the envision application are expired or aborted. 2. Documentation and Metadata 2. Documentation and Metadata Clearly describe what approach will be followed to capture the accompanying information necessary to keep data understandable Clearly describe what approach will be followed to capture the accompanying information necessary to keep data understandable and usable, for yourself and others, now and in the future (e.g., in terms of documentation levels and types required, procedures and usable, for yourself and others, now and in the future (e.g., in terms of documentation levels and types required, procedures used, Electronic Lab Notebooks, README.txt files, Codebook.tsv etc. where this information is recorded). used, Electronic Lab Notebooks, README.txt files, Codebook.tsv etc. where this information is recorded). 1. The data will be accompanied by a detailed metadata txt file denoting important characteristics (e.g. strain, material, time point,..) necessary for interpretation of the results. The key characteristics will also be denoted in the filename of the data files. 2. A detailed experimental protocol will be added to the directory of the corresponding experimental results. This step-wise description will facilitate potential future reproduction of the experiments. 3. For every deliverable in the project, a general outline txt file will be created. This file provides an overview of all the available data, the design of the experiment and the structure of the data saving. Will a metadata standard be used to make it easier to find and reuse the data? If so, please specify (where appropriate per Will a metadata standard be used to make it easier to find and reuse the data? If so, please specify (where appropriate per dataset or data type) which metadata standard will be used. If not, please specify (where appropriate per dataset or data type) dataset or data type) which metadata standard will be used. If not, please specify (where appropriate per dataset or data type) which metadata will be created to make the data easier to find and reuse. which metadata will be created to make the data easier to find and reuse. Yes Microscopy data: OME-XML metadata standard Sequencing data: MIxS metadata standard Flow cytometry data: MIFlowCyt metadata standard qPCR data: MIQE metadata standard A metadata template will be constructed in the frame of the project for data types where no general metadata standard is available. Created using DMPonline.be. Last modiﬁed 04 October 2024 3 of 6 3. Data storage & back-up during the research project 3. Data storage & back-up during the research project Where will the data be stored? Where will the data be stored? 1. Data generated by the different partners will be saved on a collective sharepoint for the data during the project. In view of the size of the raw microscopy and sequencing data,these data will be exempt from the sharepoint. 2. Additionally each partner will store their generated data on the central storage facility of their respective research units with the same structure as the sharepoints. 3. Personal copies can be made and kept on personal devices. How will the data be backed up? How will the data be backed up? 1. The collective sharepoint is backed up three times per day. 2. The internal back-up of the specific partners is managed according the procedures of their respective research institutions. Is there currently sufficient storage & backup capacity during the project? If yes, specify concisely. Is there currently sufficient storage & backup capacity during the project? If yes, specify concisely. If no or insufficient storage or backup capacities are available, then explain how this will be taken care of. If no or insufficient storage or backup capacities are available, then explain how this will be taken care of. Yes Sufficient storage space is provided by the respective research institutions. How will you ensure that the data are securely stored and not accessed or modified by unauthorized persons? How will you ensure that the data are securely stored and not accessed or modified by unauthorized persons? 1. Viewing and modification rights in sharepoint are granted based on the involvement in the specific work packages. 2. Critical documents, e.g. reports, presentations,... can be (temporarily) locked by the author(s). 3. Sharepoint provides a changelog for detecting and reverting possible unauthorized changes. 4. The internal storage of the partners provides a back-up for the sharepoint and vice versa. 5. Physical data is stored in a secured -80°C freezer at the facility with limited-access. What are the expected costs for data storage and backup during the research project? How will these costs be covered? What are the expected costs for data storage and backup during the research project? How will these costs be covered? 1. The total cost of storage are estimated on ~€3000-€3500 per year, mainly for the raw sequencing data (~4TB). 2.The costs will be covered by the respective partners using the allocated project budget (working budget: consumables). 4. Data preservation after the end of the research project 4. Data preservation after the end of the research project Which data will be retained for at least five years (or longer, in agreement with other retention policies that are applicable) after Which data will be retained for at least five years (or longer, in agreement with other retention policies that are applicable) after the end of the project? In case some data cannot be preserved, clearly state the reasons for this (e.g. legal or contractual the end of the project? In case some data cannot be preserved, clearly state the reasons for this (e.g. legal or contractual restrictions, storage/budget issues, institutional policies...). restrictions, storage/budget issues, institutional policies...). All of the generated data will be stored for minimum 5 years after the end of the project. Created using DMPonline.be. Last modiﬁed 04 October 2024 4 of 6 Where will these data be archived (stored and curated for the long-term)? Where will these data be archived (stored and curated for the long-term)? 1. Every partner will store their generated data for at least 5 years according to the storage and back-up procedures present at their research institute. 2. The project coordinator will store the total generated data in the research project using the archive network (K:) drives provided by the KU Leuven. What are the expected costs for data preservation during the expected retention period? How will these costs be covered? What are the expected costs for data preservation during the expected retention period? How will these costs be covered? In light of the size of the sequencing data (4 TB), the current storage volume of the archive drive at KU Leuven needs to be increased. The costs for an expansion of 4 TB for 5 years are estimated on € 4,000, and will be covered by the allocated project budget. 5. Data sharing and reuse 5. Data sharing and reuse Will the data (or part of the data) be made available for reuse after/during the project? In the comment section please explain per Will the data (or part of the data) be made available for reuse after/during the project? In the comment section please explain per dataset or data type which data will be made available. dataset or data type which data will be made available. Yes, in an Open Access repository All digital data will be made available upon publication. The evolved bacterial strains will not be made available in order to protect the valorisation potential of these strains. If access is restricted, please specify who will be able to access the data and under what conditions. If access is restricted, please specify who will be able to access the data and under what conditions. n/a Are there any factors that restrict or prevent the sharing of (some of) the data (e.g. as defined in an agreement with a 3rd party, Are there any factors that restrict or prevent the sharing of (some of) the data (e.g. as defined in an agreement with a 3rd party, legal restrictions)? Please explain in the comment section per dataset or data type where appropriate. legal restrictions)? Please explain in the comment section per dataset or data type where appropriate. No Where will the data be made available? If already known, please provide a repository per dataset or data type. Where will the data be made available? If already known, please provide a repository per dataset or data type. The sequencing data will be deposited International Nucleotide Sequence Database Collaboration (INSDC). When will the data be made available? When will the data be made available? The data will be made available upon publication of the corresponding research results. Which data usage licenses are you going to provide? If none, please explain why. Which data usage licenses are you going to provide? If none, please explain why. We will make use of open licenses such as CC-BY or their equivalent as our data is not considered sensitive and open licenses are often required for high impact publications. Created using DMPonline.be. Last modiﬁed 04 October 2024 5 of 6 Do you intend to add a PID/DOI/accession number to your dataset(s)? If already available, you have the option to provide it in the Do you intend to add a PID/DOI/accession number to your dataset(s)? If already available, you have the option to provide it in the comment section. comment section. Yes What are the expected costs for data sharing? How will these costs be covered? What are the expected costs for data sharing? How will these costs be covered? No costs are expected. 6. Responsibilities 6. Responsibilities Who will manage data documentation and metadata during the research project? Who will manage data documentation and metadata during the research project? The WP leaders carry the end responsibility for the correct documentation of the data generated in their respective WP Who will manage data storage and backup during the research project? Who will manage data storage and backup during the research project? Each partner is responsible for correct data storage, i.e. sharepoint and internal, for the duration of the project. The project coordinator is responsible for the coordination of the data storage Who will manage data preservation and sharing? Who will manage data preservation and sharing? The coordinator of the project will collect all the data after the project and ensure correct preservation of the data Who will update and implement this DMP? Who will update and implement this DMP? The coordinator, together with the project partners, bears the end responsibility of updating & implementing this DMP. Created using DMPonline.be. Last modiﬁed 04 October 2024 6 of 6"
}